Would be interested to hear opinions from people in terms of how this may affect us - good & bad.
Obviously IHL's mission is to address conditions that have unmet needs. If MindMed beat us to GAD with a treatment using LSD, how does that play out for our Psilocybin-assisted therapy?
The sector is certainly becoming legitimised and on one hand their news is positive for us as it gives hope that our treatment may head down the roads of approval, but at the same time, they are targeting the same addressable market as us.
Interested to hear discussion![]()
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-507
-
- There are more pages in this discussion • 392 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online